Forgot Password

  • Occams Business Research & Consulting Pvt. Ltd

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Food and Beverages » Food Additives » FFO-7060817
  • Global Beta Glucan Market- Market share and Industry Forecast to 2024

  • Publish: April 2017 | Report Code: FFO-7060817

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Global beta glucan market refers to the market of sugar which is extracted from bacteria, fungus, yeast, cereal algae. Beta glucans are used for boosting immune system in the person whose body defenses have weaken due to conditions such as stress, chronic fatigue, physical or mental stress and others. Beta glucan has huge growth opportunity in cosmetics and medicine sector as beta glucan has its application in skin health promotions focusing in antioxidant activity, anti-wrinkle activity, wound healing, and skin permeation absorption moisturizing and other. Beta glucan has wide growth opportunity in the cosmetics industry due to its health and skin benefits. Thus, rise in cosmetic industry is expected to fuel the adoption of beta glucan in cosmetic products and widen the growth opportunity of the market in cosmetics. The companies are continuously looking for development of new and innovative products to capture market potentail available for beta glucan in cosmetic sector. For instance, Ceapro Inc. (Canada) launched its cosmeceutical products JUVENTE, a new anti-aging skin care product with the active ingredients of beta glucan in Oct, 2017. Similarly, Jordan based BioNAtural company offer beta Glucan (oat powder) as an anti-aging agent and also as a restructuring replenish agent.

Growing health concern among consumers is expected to be a major factor that is boosting market growth. There are various researches across the globe that states the advantages offered by beta glucan in improving the strength and immunity of the human body. For instance, a study conducted by the US Department of Agriculture’s Beltsville Human Nutrition Research Center found that beta glucan significantly lowers the cholesterol level of men and women those have high cholesterol. In addition, a study conducted by Japanese researchers at Tokyo University Biotechnology Research Center found that “lentinan”, a type of beta glucan, has anti-tumor properties and is used for increasing the lifespan of patients suffering from breast, stomach and colorectal cancer. Furthermore, beta glucan has been widely used for escalating the immunity of the body in various circumstances such as stress, chronic fatigue, physical or mental stress, etc. In addition, it helps in maintaining the energy levels of patients undergoing radiation treatment and chemotherapies. Moreover, beta glucan is also adopted by the clinicians and physicians for treating serious diseases including AIDS, tumors and others. Immune system of the patients affected by HIV AIDS is boosted by beta glucan and it is also used in the treatment of cancer. Thus, high adoption of beta glucan due to rise in health concern is boosting growth in global beta glucan market. Moreover, various side effects of consuming beta glucan and inconsistency in regulatory norms are the major factor that are restricting the growth of market.

 

 

Source: OBRC Analysis.

Global beta glucan market is segmented on the basis of source and end-user. The market report scope is widely characterized based on category of beta glucan that include soluble and insoluble beta glucan. The total market revenue is restricted to revenues generated from net adoption of beta glucan across various end-user vertical and revenues of end-user products that contain beta glucan as an ingredient has been excluded from the report scope.

By source, global beta glucan market is further segmented into:

  • Algae
  • Bacteria
  • Cereal
  • Fungus
  • Yeast

By end user, global beta glucan market is further segmented into:

  • Animal Feed
  • Food and beverages
  • Personal care
  • Pharmaceuticals

By category, global beta glucan market is further segmented into:

  • Insoluble beta glucan
  • Soluble beta glucan

In category segment, soluble beta glucan segment accounts to largest market share in terms of revenue. The largest share of market is mainly attributed by high adoption of cereal derived beta glucan as a dietary substitute to lower risk associated with heart diseases. Furthermore, pharmaceuticals end user dominates end user segment during forecast period. The growth in pharmaceutical end user is majorly contributed by rising use of beta glucan to treat diseases such as cancer, AIDS, etc. Beta glucans can mobilize cancer fighting cells, specifically natural killer cells that play a vital role to inhibit the cancer growth. Thus, the high prevalence of diseases such as cancer, diabetes is expected to boost growth of beta glucan in pharmaceutical. Moreover, by sources segment, cereals segment is expected to experience highest CAGR during forecast period. The growth in cereals segment is driven by rise in adoption of cereal based beta glucan in food and beverages industry. Oats rich beta glucan are extensively used as fat substitute in ready-to-eat oat breakfast foods and snacks to meet the increasing demand for healthy processed food.

Global beta glucan market has divided into four region that includes;

  • North America
  • Europe (UK, Germany, France, Spain, RoE)
  • Asia Pacific (China, Japan, India, Australia, RoAPAC)
  • Rest of World

Geographically, Europe is the leading market region for global beta glucan market in terms of market revenue share. The dominance of Europe is attributed towards the fact of presence of majority of the key players. The key players include Pharmacon ASA (Norway), Tate & Lyle PLC (UK), Ohly (Germany), DSM N.V. (Netherlands) and others. Further, the increasing regulatory approvals of beta glucan across Europe is also driving the Europe beta glucan market. For instance, in April 2016, an application related to authorization of beta-glucans was accepted by FSAI (Food Safety Authority of Ireland) that was submitted by Leiber GmbH (Germany), as per Food Safety Authority of Ireland. Further, as per a research paper published by AACC International (2017), the countries cross Europe such as UK, Netherlands, Spain and Italy witnessed high dietary fiber consumption. Netherlands witnessed the top position all over the world in consuming dietary fibers in terms of grams/day. Hence, pertaining the above facts, OBRC analysis finds Europe as the second most favorable region for investment over the forecast period (2017-2024). However, North America is expected to emerge as the fastest growing region during the forecast period 2017-2024. Factors such as presence of major key players and initiatives taken by them is promoting growth in North America beta glucan market.

Major market players of the global Beta glucan market are:

  • Cargill Inc. (U.S.)
  • Tate & Lyle (U.K.)
  • Kerry Group PLC (Israel)
  • OHLY (Germany)
  • Koninklijke DSM N.V.
  • Others

Market players are adopting numerous strategies such as partnership, collaboration, product launch and merger & acquisition  to sustain in the dynamic market. Whereas, product launch is amongst the key strategy adopted by the companies in the global Beta glucan market.

For Example; In August 2015, Ohly (Germany) announced the launch of "Auxoferm". This product is Saccharomyces boulardii based. that is a probiotic yeast inclined towards transforming efficacy of the oral rehydration systems used by patients across the globe.

 In 2015, Wellmune from Biothera Inc., was acquired by Kerry Group Plc (Israel). Wellmune is a supplement ingredient and natural food and beverages that helps to strengthen the immune system and it was a clinically proven.  This acquisition is expected to result in increase in geographical presence and market share of the company.

The report covers detailed analysis of companies which comprises overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis.

Key reason to buy the report:

  • The report includes market estimation, forecast and analysis for the forecast year 2017-2024.
  • Report includes detailed analysis of segments such as source, end user and category of global Beta glucan market.
  • Identify and understand the strength, opportunities, challenges and threat of the global Beta glucan market.
  • Covers details analysis of Porters 5 force model and other strategic models and covers revenues, market share analysis, and competitive landscape analysis of major players of global Beta glucan market.
  • Detailed analysis of various the regulatory policies which are affecting the global beta glucan market.

How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape, with giving extensive SCOT analysis of key companies. 

Key findings of the global Beta glucan market

  • Key factor driving the growth in market is rising health concern.  
  • Europe is the largest market region in terms of market revenue share.
  • Pharmaceuticals is the dominating application segment.
  • Merger & acquisition is the key strategy adopted by the companies with in market.

 

 

 

1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. MARKET DEFINITION AND SCOPE
2.2. EVOLUTION & TRANSITION: GLOBAL BETA GLUCAN MARKET
2.3. REGULATORY FRAMEWORK
2.4. INDUSTRY STRUCTURE
2.5. ESTIMATION ANALYSIS
2.6. TOTAL MARKET ANALYSIS
2.6.1. TOP 5 OPPORTUNITY MARKETS
2.6.2. TOP 5 FINDINGS
2.6.3. TOP 3 COMPETITIVE STRATEGIES
2.6.4. TOP 5 COMPANIES
2.7. COMPETITIVE ANALYSIS
2.7.1. MARKET SHARE ANALYSIS
2.8. STRATEGIC ANALYSIS
2.8.1. SEE-SAW ANALYSIS
2.8.2. 360 DEGREE INDUSTRY ANALYSIS
2.8.3. KEY BUYING CRITERIA AND CONSUMER ANALYSIS 
2.8.4. INVESTMENT VS. ADOPTION MODEL
2.8.5. PORTERS FIVE FORCE MODEL
2.9. KEY CONCLUSIONS & STRATEGIC RECOMMENDATIONS 
2.9.1. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITIES BY REGIONS
3. MARKET DETERMINANTS 
3.1. DRIVERS & IMPACT ANALYSIS
3.1.1. INCREASING DEMAND FOR PROCESSED AND READY TO EAT FOOD
3.1.2. INCREASED USAGE IN PROCESSED FOODS AS FAT SUBSTITUTES
3.1.3. RISING DISPOSABLE INCOME
3.1.4. GROWING DEMAND FOR YEAST SPECIALTY PRODUCTS
3.2. RESTRAINTS & IMPACT ANALYSIS
3.2.1. VARIOUS SIDE EFFECTS OF CONSUMING BETA GLUCAN
3.2.2. INCONSISTENT REGULATORY STRUCTURE ACROSS COUNTRIES
3.3. OPPORTUNITIES & IMPACT ANALYSIS
3.3.1. EXPANDING FUNCTIONAL FOOD INDUSTRY IN EMERGING ECONOMIES
3.3.2. HIGH USAGE IN NUTRACEUTICAL AND COSMETIC INDUSTRY
3.4. CHALLENGES & IMPACT ANALYSIS
3.4.1. HIGH COST OF BETA-GLUCAN EXTRACTION
3.4.2. SHORTAGE OF MAJOR RAW MATERIALS SUCH AS MOLASSES
4. GLOBAL BETA GLUCAN MARKET BY SOURCE
4.1. ESTIMATION METHODOLOGY & DECISION BACKING DATABASE 
4.2. MARKET DEFINITION AND SCOPE
4.3. OPPORTUNITY MATRIX
4.4. MARKET SEGMENT ANALYSIS A COMPARATIVE STUDY
4.5. MARKET SEGMENTATION
4.5.1. GLOBAL ALGAE MARKET
4.5.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.5.1.2. MARKET DETERMINANTS & ADOPTION SCENARIO
4.5.1.3. MARKET PARTICIPANTS AND PRODUCTS
4.5.1.4. KEY CONCLUSIONS
4.5.2. GLOBAL BACTERIA MARKET
4.5.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.5.2.2. MARKET DETERMINANTS & ADOPTION SCENARIO
4.5.2.3. MARKET PARTICIPANTS AND PRODUCTS
4.5.2.4. KEY CONCLUSIONS
4.5.3. GLOBAL CEREAL MARKET
4.5.3.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.5.3.2. MARKET DETERMINANTS & ADOPTION SCENARIO
4.5.3.3. MARKET PARTICIPANTS AND PRODUCTS
4.5.3.4. KEY CONCLUSIONS
4.5.4. GLOBAL FUNGUS MARKET
4.5.4.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.5.4.2. MARKET DETERMINANTS & ADOPTION SCENARIO
4.5.4.3. MARKET PARTICIPANTS AND PRODUCTS
4.5.4.4. KEY CONCLUSIONS
4.5.5. GLOBAL YEAST MARKET
4.5.5.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.5.5.2. MARKET DETERMINANTS & ADOPTION SCENARIO
4.5.5.3. MARKET PARTICIPANTS AND PRODUCTS
4.5.5.4. KEY CONCLUSIONS
5. GLOBAL BETA GLUCAN MARKET BY END USER
5.1. ESTIMATION METHODOLOGY & DECISION BACKING DATABASE 
5.2. MARKET DEFINITION AND SCOPE
5.3. OPPORTUNITY MATRIX
5.4. MARKET SEGMENT ANALYSIS A COMPARATIVE STUDY
5.5. MARKET SEGMENTATION
5.5.1. GLOBAL ANIMAL FEED MARKET
5.5.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
5.5.1.2. MARKET DETERMINANTS & ADOPTION SCENARIO
5.5.1.3. MARKET PARTICIPANTS AND PRODUCTS
5.5.1.4. KEY CONCLUSIONS
5.5.2. GLOBAL FOOD & BEVERAGES MARKET
5.5.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
5.5.2.2. MARKET DETERMINANTS & ADOPTION SCENARIO
5.5.2.3. MARKET PARTICIPANTS AND PRODUCTS
5.5.2.4. KEY CONCLUSIONS
5.5.3. GLOBAL PERSONAL CARE MARKET
5.5.3.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
5.5.3.2. MARKET DETERMINANTS & ADOPTION SCENARIO
5.5.3.3. MARKET PARTICIPANTS AND PRODUCTS
5.5.3.4. KEY CONCLUSIONS
5.5.4. GLOBAL PHARMACEUTICALS MARKET
5.5.4.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
5.5.4.2. MARKET DETERMINANTS & ADOPTION SCENARIO
5.5.4.3. MARKET PARTICIPANTS AND PRODUCTS
5.5.4.4. KEY CONCLUSIONS
6. GLOBAL BETA GLUCAN MARKET BY CATEGORY
6.1. ESTIMATION METHODOLOGY & DECISION BACKING DATABASE 
6.2. MARKET DEFINITION AND SCOPE
6.3. OPPORTUNITY MATRIX
6.4. MARKET SEGMENT ANALYSIS A COMPARATIVE STUDY
6.5. MARKET SEGMENTATION
6.5.1. GLOBAL INSOLUBLE BETA GLUCAN MARKET
6.5.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.5.1.2. MARKET DETERMINANTS & ADOPTION SCENARIO
6.5.1.3. MARKET PARTICIPANTS AND PRODUCTS
6.5.1.4. KEY CONCLUSIONS
6.5.2. GLOBAL SOLUBLE BETA GLUCAN MARKET
6.5.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.5.2.2. MARKET DETERMINANTS & ADOPTION SCENARIO
6.5.2.3. MARKET PARTICIPANTS AND PRODUCTS
6.5.2.4. KEY CONCLUSIONS
7. COMPETITIVE LANDSCAPE
7.1. LIST OF KEY STRATEGIES
7.1.1. PARTNERSHIPS LIST
7.1.2. COLLABORATION, MERGERS & ACQUISITION LIST
7.1.3. PRODUCT DEVELOPMENT, PRODUCT LAUNCH LIST
7.1.4. INVESTMENT, EXPANISON, JOINT VENTURES LIST
8. GEOGRAPHIC ANALYSIS
8.1. MARKET SEGMENT ANALYSIS A COMPARATIVE STUDY
8.2. ESTIMATION METHODOLOGY & DECISION BACKING DATABASE 
8.3. OPPORTUNITY MATRIX
8.4. GLOBAL BETA GLUCAN MARKET BY REGION 205-2024  
8.4.1. NORTH AMERICA
8.4.1.1. INDUSTRY ANALYSIS 
8.4.1.2. TOP COUNTRY ANALYSIS
8.4.1.2.1. U.S. 
8.4.1.2.1.1. MARKET FORECASTS AND ESTIMATION 2015-2024 ($ MILLION)
8.4.1.2.1.2. MARKET PARTICIPANTS AND PRODUCTS
8.4.1.2.1.3. KEY CONCLUSIONS
8.4.1.2.2. CANADA
8.4.1.2.2.1. MARKET FORECASTS AND ESTIMATION 2015-2024 ($ MILLION)
8.4.1.2.2.2. MARKET PARTICIPANTS AND PRODUCTS
8.4.1.2.2.3. KEY CONCLUSIONS
8.4.2. EUROPE
8.4.2.1. INDUSTRY ANALYSIS 
8.4.2.2. TOP COUNTRY ANALYSIS
8.4.2.2.1. UK
8.4.2.2.1.1. MARKET FORECASTS AND ESTIMATION 2015-2024 ($ MILLION)
8.4.2.2.1.2. MARKET PARTICIPANTS AND PRODUCTS
8.4.2.2.1.3. KEY CONCLUSIONS
8.4.2.2.2. FRANCE
8.4.2.2.2.1. MARKET FORECASTS AND ESTIMATION 2015-2024 ($ MILLION)
8.4.2.2.2.2. MARKET PARTICIPANTS AND PRODUCTS
8.4.2.2.2.3. KEY CONCLUSIONS
8.4.2.2.3. GERMANY
8.4.2.2.3.1. MARKET FORECASTS AND ESTIMATION 2015-2024 ($ MILLION)
8.4.2.2.3.2. MARKET PARTICIPANTS AND PRODUCTS
8.4.2.2.3.3. KEY CONCLUSIONS
8.4.2.2.4. SPAIN
8.4.2.2.4.1. MARKET FORECASTS AND ESTIMATION 2015-2024 ($ MILLION)
8.4.2.2.4.2. MARKET PARTICIPANTS AND PRODUCTS
8.4.2.2.4.3. KEY CONCLUSIONS
8.4.2.2.5. REST OF EUROPE
8.4.2.2.5.1. MARKET FORECASTS AND ESTIMATION 2015-2024 ($ MILLION)
8.4.2.2.5.2. MARKET PARTICIPANTS AND PRODUCTS
8.4.2.2.5.3. KEY CONCLUSIONS
8.4.3. ASIA PACIFIC
8.4.3.1. INDUSTRY ANALYSIS 
8.4.3.2. TOP COUNTRY ANALYSIS
8.4.3.2.1. CHINA
8.4.3.2.1.1. MARKET FORECASTS AND ESTIMATION 2015-2024 ($ MILLION)
8.4.3.2.1.2. MARKET PARTICIPANTS AND PRODUCTS
8.4.3.2.1.3. KEY CONCLUSIONS
8.4.3.2.2. INDIA
8.4.3.2.2.1. MARKET FORECASTS AND ESTIMATION 2015-2024 ($ MILLION)
8.4.3.2.2.2. MARKET PARTICIPANTS AND PRODUCTS
8.4.3.2.2.3. KEY CONCLUSIONS
8.4.3.2.3. JAPAN
8.4.3.2.3.1. MARKET FORECASTS AND ESTIMATION 2015-2024 ($ MILLION)
8.4.3.2.3.2. MARKET PARTICIPANTS AND PRODUCTS
8.4.3.2.3.3. KEY CONCLUSIONS
8.4.3.2.4. AUSTRALIA
8.4.3.2.4.1. MARKET FORECASTS AND ESTIMATION 2015-2024 ($ MILLION)
8.4.3.2.4.2. MARKET PARTICIPANTS AND PRODUCTS
8.4.3.2.4.3. KEY CONCLUSIONS
8.4.3.2.5. REST OF ASIA PACIFIC
8.4.3.2.5.1. MARKET FORECASTS AND ESTIMATION 2015-2024 ($ MILLION)
8.4.3.2.5.2. MARKET PARTICIPANTS AND PRODUCTS
8.4.3.2.5.3. KEY CONCLUSIONS
8.4.4. ROW
8.4.4.1. INDUSTRY ANALYSIS 
8.4.4.2. TOP COUNTRY ANALYSIS
8.4.4.2.1. LATIN AMERICA
8.4.4.2.1.1. MARKET FORECASTS AND ESTIMATION 2015-2024 ($ MILLION)
8.4.4.2.1.2. MARKET PARTICIPANTS AND PRODUCTS
8.4.4.2.1.3. KEY CONCLUSIONS
8.4.4.2.2. MIDDLE EAST & AFRICA 
8.4.4.2.2.1. MARKET FORECASTS AND ESTIMATION 2015-2024 ($ MILLION)
8.4.4.2.2.2. MARKET PARTICIPANTS AND PRODUCTS
8.4.4.2.2.3. KEY CONCLUSIONS
9. COMPANY PROFILES 
9.1. ALLTECH BIOTECHNOLOGY (U.S.)
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. STRATEGIC INITIATIVES 
9.1.4. SCOT ANALYSIS 
9.1.5. STRATEGIC ANALYSIS
9.2.   ASSOCIATED BRITISH FOODS PLC (UK.)
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES 
9.2.4. SCOT ANALYSIS 
9.2.5. STRATEGIC ANALYSIS
9.3. BIOTHERA PHARMACEUTICALS INC. (U.S.)
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. STRATEGIC INITIATIVES 
9.3.4. SCOT ANALYSIS 
9.3.5. STRATEGIC ANALYSIS
9.4. BIOTEC PHARMACON ASA (NORWAY)
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. STRATEGIC INITIATIVES 
9.4.4. SCOT ANALYSIS 
9.4.5. STRATEGIC ANALYSIS
9.5. CARGILL INC. (U.S.)
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVES 
9.5.4. SCOT ANALYSIS 
9.5.5. STRATEGIC ANALYSIS
9.6. CHR. HANSEN A/S. (DENMARK)
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVES 
9.6.4. SCOT ANALYSIS
9.6.5. STRATEGIC ANALYSIS
9.7.         DSM N.V. (NETHERLANDS)
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES 
9.7.4. SCOT ANALYSIS 
9.7.5. STRATEGIC ANALYSIS
9.8. LESAFFRE HUMAN CARE (FRANCE)
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVES 
9.8.4. SCOT ANALYSIS 
9.8.5. STRATEGIC ANALYSIS
9.9.   KERRY GROUP PLC (IRELAND)
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVES 
9.9.4. SCOT ANALYSIS 
9.9.5. STRATEGIC ANALYSIS
9.10.   MILLIPORESIGMA (U.S.)
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. STRATEGIC INITIATIVES 
9.10.4. SCOT ANALYSIS 
9.10.5. STRATEGIC ANALYSIS 
9.11.   OHLY (GERMANY)
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVES 
9.11.4. SCOT ANALYSIS 
9.11.5. STRATEGIC ANALYSIS
9.12. PHARMACON ASA (NORWAY)
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. STRATEGIC INITIATIVES 
9.12.4. SCOT ANALYSIS 
9.12.5. STRATEGIC ANALYSIS
9.13. SPECIALTY BIOTECH CO., LTD (THAILAND)
9.13.1. OVERVIEW
9.13.2. PRODUCT PORTFOLIO
9.13.3. STRATEGIC INITIATIVES 
9.13.4. SCOT ANALYSIS 
9.13.5. STRATEGIC ANALYSIS
9.14. SUPER BETA GLUCAN (U.S.)
9.14.1. OVERVIEW
9.14.2. PRODUCT PORTFOLIO
9.14.3. STRATEGIC INITIATIVES 
9.14.4. SCOT ANALYSIS 
9.14.5. STRATEGIC ANALYSIS
9.15. TATE & LYLE PLC (UK)
9.15.1. OVERVIEW
9.15.2. PRODUCT PORTFOLIO
9.15.3. STRATEGIC INITIATIVES 
9.15.4. SCOT ANALYSIS
9.15.5. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL BETA GLUCAN MARKET BY SOURCE 2015-2024 ($ MILLION)
2. GLOBAL ALGAE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
3. GLOBAL BACTERIA MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
4. GLOBAL CEREAL MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
5. GLOBAL FUNGUS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
6. GLOBAL YEAST MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
7. GLOBAL BETA GLUCAN MARKET BY END USER 2015-2024 ($ MILLION)
8. GLOBAL ANIMAL FEED MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
9. GLOBAL FOOD & BEVERAGES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
10. GLOBAL PERSONAL CARE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION) 
11. GLOBAL PHARMACEUTICALS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
12. GLOBAL BETA GLUCAN MARKET BY CATEGORY 2015-2024 ($ MILLION)
13. GLOBAL INSOLUBLE BETA GLUCAN MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
14. GLOBAL SOLUBLE BETA GLUCAN MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
15. GLOBAL BETA GLUCAN MARKET BY REGION 20152024 ($ MILLION)
16. NORTH AMERICA BETA GLUCAN MARKET 2015-2024 ($ MILLION)
17. EUROPE BETA GLUCAN MARKET 2015-2024 ($ MILLION)
18. ASIA PACIFIC BETA GLUCAN MARKET 2015-2024 ($ MILLION)
19. REST OF THE WORLD BETA GLUCAN MARKET 2015-2024 ($ MILLION)
20. NORTH AMERICA BETA GLUCAN MARKET BY SOURCE 2015-2024 ($ MILLION)
21. EUROPE BETA GLUCAN MARKET BY SOURCE 2015-2024 ($ MILLION)
22. ASIA PACIFIC BETA GLUCAN MARKET BY SOURCE 2015-2024 ($ MILLION)
23. REST OF THE WORLD BETA GLUCAN MARKET BY SOURCE 2015-2024 ($ MILLION)
24. NORTH AMERICA BETA GLUCAN MARKET BY END USER 2015-2024 ($ MILLION)
25. EUROPE BETA GLUCAN MARKET BY END USER 2015-2024 ($ MILLION)
26. ASIA PACIFIC BETA GLUCAN MARKET BY END USER 2015-2024 ($ MILLION) 
27. REST OF THE WORLD BETA GLUCAN MARKET BY END USER 2015-2024 ($ MILLION)
28. NORTH AMERICA BETA GLUCAN MARKET BY CATEGORY 2015-2024 ($ MILLION)
29. EUROPE BETA GLUCAN MARKET BY CATEGORY 2015-2024 ($ MILLION)
30. ASIA PACIFIC BETA GLUCAN MARKET BY CATEGORY 2015-2024 ($ MILLION)
31. REST OF THE WORLD BETA GLUCAN MARKET BY CATEGORY 2015-2024 ($ MILLION)
32. UNITED STATES BETA GLUCAN MARKET BY CATEGORY 2015-2024 ($ MILLION)
33. CANADA BETA GLUCAN MARKET BY CATEGORY 2015-2024 ($ MILLION)
34. UK BETA GLUCAN MARKET BY CATEGORY 2015-2024 ($ MILLION)
35. GERMANY BETA GLUCAN MARKET BY CATEGORY 2015-2024 ($ MILLION)
36. FRANCE BETA GLUCAN MARKET BY CATEGORY 2015-2024 ($ MILLION)
37. SPAIN BETA GLUCAN MARKET BY CATEGORY 2015-2024 ($ MILLION)
38. ROE BETA GLUCAN MARKET BY CATEGORY 2015-2024 ($ MILLION)
39. CHINA BETA GLUCAN MARKET BY CATEGORY 2015-2024 ($ MILLION)
40. JAPAN BETA GLUCAN MARKET BY CATEGORY 2015-2024 ($ MILLION)
41. AUSTRALIA BETA GLUCAN MARKET BY CATEGORY 2015-2024 ($ MILLION)
42. ROAPAC BETA GLUCAN MARKET BY CATEGORY 2015-2024 ($ MILLION)
43. LATIN AMERICA BETA GLUCAN MARKET BY CATEGORY 2015-2024 ($ MILLION)
44. MENA BETA GLUCAN MARKET BY CATEGORY 2015-2024 ($ MILLION)
LIST OF FIGURES
1. GLOBAL ALGAE MARKET 2015-2024 ($ MILLION)
2. GLOBAL BACTERIA MARKET 2015-2024 ($ MILLION)
3. GLOBAL CEREAL MARKET 2015-2024 ($ MILLION)
4. GLOBAL FUNGUS MARKET 2015-2024 ($ MILLION)
5. GLOBAL YEAST MARKET 2015-2024 ($ MILLION)
6. GLOBAL ANIMAL FEED MARKET 2015-2024 ($ MILLION)
7. GLOBAL FOOD & BEVERAGES MARKET 2015-2024 ($ MILLION)
8. GLOBAL PERSONAL CARE MARKET 2015-2024 ($ MILLION)
9. GLOBAL PHARMACEUTICALS MARKET 2015-2024 ($ MILLION)
10. GLOBAL INSOLUBLE BETA GLUCAN MARKET 2015-2024 ($ MILLION)
11. GLOBAL SOLUBLE BETA GLUCAN MARKET 2015-2024 ($ MILLION)
12. UNITED STATES (U.S.) BETA GLUCAN MARKET 2015-2024 ($ MILLION)
13. CANADA BETA GLUCAN MARKET2015-2024 ($MILLION)
14. UNITED KINGDOM (UK) TITANIUM DIOXIDE MARKET2015-2024 ($ MILLION)
15. FRANCE BETA GLUCAN MARKET 2015-2024 ($ MILLION)
16. GERMANY BETA GLUCAN MARKET 2015-2024 ($ MILLION)
17. SPAIN BETA GLUCAN MARKET 2015-2024 ($ MILLION)
18. ITALY BETA GLUCAN MARKET 2015-2024 ($ MILLION)
19. ROE BETA GLUCAN MARKET 2015-2024 ($ MILLION)
20. INDIA BETA GLUCAN MARKET 2015-2024 ($ MILLION)
21. CHINA BETA GLUCAN MARKET 2015-2024 ($ MILLION)
22. JAPAN BETA GLUCAN MARKET 2015-2024 ($ MILLION)
23. KOREA BETA GLUCAN MARKET 2015-2024 ($ MILLION)
24. AUSTRALIA BETA GLUCAN MARKET 2015-2024 ($ MILLION)
25. ROW APAC BETA GLUCAN MARKET 2015-2024 ($ MILLION)
26. LATIN AMERICA BETA GLUCAN MARKET 2015-2024 ($ MILLION)
27. MENA BETA GLUCAN MARKET 2015-2024 ($ MILLION) 
 
 

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 8390547755

Email: info@occamsresearch.com

 

 

Go To Top
viewthroughconversion